• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢神经系统的修复机制:从轴突发芽到髓鞘再生。

Repair mechanisms of the central nervous system: From axon sprouting to remyelination.

作者信息

Gluck Lauren, Gerstein Brittany, Kaunzner Ulrike W

机构信息

Montefiore Medical Center, 1250 Waters Place Tower 2, Bronx, NY 10461, USA.

Weill-Cornell-Medicine, Department of Neurology, 1305 York Avenue, New York City, 10021, USA.

出版信息

Neurotherapeutics. 2025 May 9:e00583. doi: 10.1016/j.neurot.2025.e00583.

DOI:10.1016/j.neurot.2025.e00583
PMID:40348704
Abstract

The central nervous system (CNS), comprising the brain, spinal cord, and optic nerve, has limited regenerative capacity, posing significant challenges in treating neurological disorders. Recent advances in neuroscience and neurotherapeutics have introduced promising strategies to stimulate CNS repair, particularly in the context of neurodegenerative diseases such as multiple sclerosis. This review explores the complex interplay between inflammation, demyelination, and remyelination possibilities. Glial cells, including oligodendrocyte precursors, oligodendrocytes, astrocytes and microglia play dual roles in injury response, with reactive gliosis promoting repair but also potentially inhibiting recovery through glial scar formation. There is also an emphasis on axonal regeneration, axonal sprouting and stem cell therapies. We highlight the role of neuroplasticity in recovery post-injury and the limited regenerative potential of axons in the CNS due to inhibitory factors such as myelin-associated inhibitors. Moreover, neurotrophic factors support neuronal survival and axonal growth, while stem cell-based approaches offer promise for replacing lost neurons and glial cells. However, challenges such as stem cell survival, integration, and risk of tumor formation remain. Furthermore, we examine the role of neurogenesis in CNS repair and the remodeling of the extracellular matrix, which can facilitate regeneration. Through these diverse mechanisms, ongoing research aims to overcome the intrinsic and extrinsic barriers to CNS repair and advance therapeutic strategies for neurological diseases.

摘要

中枢神经系统(CNS)由脑、脊髓和视神经组成,其再生能力有限,这给神经系统疾病的治疗带来了重大挑战。神经科学和神经治疗学的最新进展引入了有前景的策略来刺激中枢神经系统修复,特别是在多发性硬化症等神经退行性疾病的背景下。本综述探讨了炎症、脱髓鞘和再髓鞘化可能性之间的复杂相互作用。胶质细胞,包括少突胶质细胞前体、少突胶质细胞、星形胶质细胞和小胶质细胞在损伤反应中发挥双重作用,反应性胶质增生促进修复,但也可能通过胶质瘢痕形成抑制恢复。文中还强调了轴突再生、轴突发芽和干细胞疗法。我们强调了神经可塑性在损伤后恢复中的作用,以及由于髓磷脂相关抑制剂等抑制因素,中枢神经系统中轴突的再生潜力有限。此外,神经营养因子支持神经元存活和轴突生长,而基于干细胞的方法为替代丢失的神经元和胶质细胞带来了希望。然而,干细胞存活、整合和肿瘤形成风险等挑战仍然存在。此外,我们研究了神经发生在中枢神经系统修复和细胞外基质重塑中的作用,细胞外基质重塑可以促进再生。通过这些不同的机制,正在进行的研究旨在克服中枢神经系统修复的内在和外在障碍,并推进神经系统疾病的治疗策略。

相似文献

1
Repair mechanisms of the central nervous system: From axon sprouting to remyelination.中枢神经系统的修复机制:从轴突发芽到髓鞘再生。
Neurotherapeutics. 2025 May 9:e00583. doi: 10.1016/j.neurot.2025.e00583.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.中枢神经系统罕见的非多发性硬化脱髓鞘疾病
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8.
4
Cellular and Molecular Interactions in CNS Injury: The Role of Immune Cells and Inflammatory Responses in Damage and Repair.中枢神经系统损伤中的细胞与分子相互作用:免疫细胞及炎症反应在损伤与修复中的作用
Cells. 2025 Jun 18;14(12):918. doi: 10.3390/cells14120918.
5
Short-Term Memory Impairment短期记忆障碍
6
Cell-based therapies for traumatic optic neuropathy: Recent advances, challenges, and perspectives.创伤性视神经病变的细胞疗法:最新进展、挑战与展望
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01322.
7
Neurorehabilitation and white matter repair in traumatic spinal cord injury: a dialogue between clinical and preclinical studies.创伤性脊髓损伤中的神经康复与白质修复:临床研究与临床前研究的对话
Front Neurol. 2025 Jun 18;16:1532056. doi: 10.3389/fneur.2025.1532056. eCollection 2025.
8
Lesion-remote astrocytes govern microglia-mediated white matter repair.损伤远端星形胶质细胞调控小胶质细胞介导的白质修复。
bioRxiv. 2024 Mar 17:2024.03.15.585251. doi: 10.1101/2024.03.15.585251.
9
Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation.多发性硬化症进展性残疾的途径:神经胶质细胞在慢性中枢神经系统炎症中的作用
Glia. 2025 Oct;73(10):1928-1950. doi: 10.1002/glia.70044. Epub 2025 May 23.
10
Remyelination in the Central Nervous System.中枢神经系统的髓鞘再生
Cold Spring Harb Perspect Biol. 2024 Mar 1;16(3):a041371. doi: 10.1101/cshperspect.a041371.

引用本文的文献

1
Special Edition: Therapeutic advances in multiple sclerosis.特刊:多发性硬化症的治疗进展
Neurotherapeutics. 2025 Jul;22(4):e00697. doi: 10.1016/j.neurot.2025.e00697. Epub 2025 Jul 11.

本文引用的文献

1
Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis.富马酸氯马斯汀通过增强细胞焦亡加速进展性多发性硬化症的残疾累积。
J Clin Invest. 2025 May 15;135(10). doi: 10.1172/JCI183941.
2
Antioxidant Therapies in the Treatment of Multiple Sclerosis.抗氧化疗法治疗多发性硬化症。
Biomolecules. 2024 Oct 8;14(10):1266. doi: 10.3390/biom14101266.
3
CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents.经 CRISPR 编辑的人胚胎干细胞源性少突胶质前体细胞可改善啮齿动物的髓鞘再生。
Nat Commun. 2024 Oct 9;15(1):8570. doi: 10.1038/s41467-024-52444-w.
4
Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases.非瑟酮作为一种衰老治疗剂:与年龄相关疾病的证据和前景
Mech Ageing Dev. 2024 Dec;222:111995. doi: 10.1016/j.mad.2024.111995. Epub 2024 Oct 9.
5
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.评估辛伐他汀在延缓继发进展型多发性硬化症残疾进展中的有效性(MS-STAT2):英国一项多中心、随机对照、双盲、3期临床试验方案
BMJ Open. 2024 Sep 16;14(9):e086414. doi: 10.1136/bmjopen-2024-086414.
6
Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.采用一种选择性、可穿透血脑屏障的毒蕈碱 M1 受体拮抗剂来靶向作用,以促进多发性硬化症中的髓鞘再生。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2407974121. doi: 10.1073/pnas.2407974121. Epub 2024 Jul 31.
7
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.二甲双胍治疗多发性硬化症的附加临床试验,以评估脑髓鞘再生和神经退行性变(MACSiMiSE-BRAIN):一项多中心随机安慰剂对照临床试验的研究方案。
Front Immunol. 2024 Feb 21;15:1362629. doi: 10.3389/fimmu.2024.1362629. eCollection 2024.
8
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.诱导多能干细胞(iPSCs):诱导的分子机制与应用。
Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0.
9
Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5×FAD mice.雷帕霉素激活线粒体自噬可增强5×FAD小鼠的线粒体功能和认知能力。
Behav Brain Res. 2024 Apr 12;463:114889. doi: 10.1016/j.bbr.2024.114889. Epub 2024 Feb 1.
10
Clinical applications of stem cell-derived exosomes.干细胞衍生的外泌体的临床应用。
Signal Transduct Target Ther. 2024 Jan 12;9(1):17. doi: 10.1038/s41392-023-01704-0.